反応式
[CH3:1][O:2][C:3]1[N:8]=[C:7]2[NH:9][C:10](=[O:25])[N:11]([CH:12]3[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14][CH2:13]3)[C:6]2=[CH:5][CH:4]=1.Cl>CO.CCOCC>[CH3:1][O:2][C:3]1[N:8]=[C:7]2[NH:9][C:10](=[O:25])[N:11]([CH:12]3[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]3)[C:6]2=[CH:5][CH:4]=1参加物
5
実験手順
5-Methoxy-2-oxo-1-(1-t-butoxycarbonylpiperidin-4-yl)-2,3-dihydro-1H-imidazo[4,5-b]pyridine (100 mg, 0.287 mmol) was dissolved in methanol (2.5 mL) and a solution of 2N hydrochloric acid in ether (3 mL) was added at room temperature. After 2 h, the volatiles were removed in vacuo, to give the title compound (61 mg). MS 249.1 (M+1).
後処理
- customthe volatiles were removed in vacuo
出典と根拠
- ORDレコード
- ord-34a5c9abb693481cb29c1ce40ebbef2a
- 出典データセット
- uspto-grants-2008_11
- 特許番号
- US07452903B2
関連ノート
読み込み中…